IMNP
Vanguard Group’s Immune Pharmaceuticals Inc. IMNP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-136,841
| Closed | -$26K | – | 4202 |
|
2018
Q2 | $26K | Hold |
136,841
| – | – | ﹤0.01% | 4119 |
|
2018
Q1 | $48K | Sell |
136,841
-278,677
| -67% | -$97.8K | ﹤0.01% | 4068 |
|
2017
Q4 | $237K | Buy |
415,518
+189,081
| +84% | +$108K | ﹤0.01% | 3901 |
|
2017
Q3 | $342K | Sell |
226,437
-3,332
| -1% | -$5.03K | ﹤0.01% | 3815 |
|
2017
Q2 | $715K | Sell |
229,769
-4,753,248
| -95% | -$14.8M | ﹤0.01% | 3656 |
|
2017
Q1 | $728K | Buy |
4,983,017
+1,001,138
| +25% | +$146K | ﹤0.01% | 3665 |
|
2016
Q4 | $725K | Buy |
3,981,879
+1,897,964
| +91% | +$346K | ﹤0.01% | 3657 |
|
2016
Q3 | $584K | Buy |
2,083,915
+1,871,015
| +879% | +$524K | ﹤0.01% | 3723 |
|
2016
Q2 | $86K | Hold |
212,900
| – | – | ﹤0.01% | 4040 |
|
2016
Q1 | $92K | Buy |
212,900
+72,900
| +52% | +$31.5K | ﹤0.01% | 4037 |
|
2015
Q4 | $102K | Buy |
140,000
+73,959
| +112% | +$53.9K | ﹤0.01% | 4079 |
|
2015
Q3 | $78K | Buy |
66,041
+34,874
| +112% | +$41.2K | ﹤0.01% | 4114 |
|
2015
Q2 | $60K | Buy |
+31,167
| New | +$60K | ﹤0.01% | 4147 |
|